UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 231

Sortiert nach

Docetaxel is effective in heavily pretreated patients with disseminated nasopharyngeal carcinoma

Annals of oncology, 2011-03, Vol.22 (3), p.718-722

2011

Volltextzugriff (PDF)

Clinicopathological characteristics and outcome of advanced ROS1-positive non-small cell lung cancer in Asian patients

Annals of oncology, 2019-04, Vol.30, p.ii54-ii54

2019

Volltextzugriff (PDF)

Real world data on epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI) use in advanced/metastatic non-small cell lung cancer (NSCLC) with EGFR mutations in Singapore

Annals of oncology, 2018-11, Vol.29, p.ix161-ix161

2018

Volltextzugriff (PDF)

Somatostatin receptor 2 expression and clinical significance in pulmonary lymphoepithelioma-like carcinoma

Annals of oncology, 2018-10, Vol.29, p.viii678-viii678

2018

Volltextzugriff (PDF)

Nuclear expression of MATK is a novel marker of type II enteropathy-associated T-cell lymphoma

Leukemia, 2011-03, Vol.25 (3), p.555-557

2011

Volltextzugriff (PDF)

A Phase 1 dose-finding and pharmacodynamic study of rapamycin in combination with bevacizumab in patients with unresectable hepatocellular carcinoma

European journal of cancer (1990), 2013-03, Vol.49 (5), p.999-1008

2013

Volltextzugriff (PDF)

Gefitinib, cisplatin, and concurrent radiotherapy for locally advanced head and neck cancer: EGFR FISH, protein expression, and mutational status are not predictive biomarkers

Annals of oncology, 2012-04, Vol.23 (4), p.1010-1016

2012

Volltextzugriff (PDF)

Pan-Asian adaptation of the EHNS–ESMO–ESTRO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with squamous cell carcinoma of the head and neck

ESMO open, 2021-12, Vol.6 (6), p.100309, Article 100309

2021

Volltextzugriff (PDF)

Herbal medicines and perioperative care

JAMA : the journal of the American Medical Association, 2001-07, Vol.286 (2), p.208

2001

Volltextzugriff (PDF)

Barriers to implementing a national health screening program for men in Malaysia: An online survey of healthcare providers

Malaysian family physician, 2020, Vol.15 (1), p.6-14

2020

Volltextzugriff (PDF)

Different cellular p16INK4a localisation may signal different survival outcomes in head and neck cancer

British journal of cancer, 2012-06, Vol.107 (3), p.482-490

2012

Volltextzugriff (PDF)

Assessing subjective and psychomotor effects of the herbal medication valerian in healthy volunteers

Pharmacology, biochemistry and behavior, 2004-05, Vol.78 (1), p.57-64

2004

Volltextzugriff (PDF)

911P Post-radiotherapy (RT) Epstein-Barr virus (EBV) DNA dynamics identifies optimal timepoint for stratification of high-risk nasopharyngeal carcinoma (NPC)

Annals of oncology, 2023-10, Vol.34, p.S578-S578

2023

Volltextzugriff (PDF)

227MO Characterization of minimal residual disease (MRD) post-radiotherapy (RT) in nasopharyngeal carcinoma (NPC) patients identifies a favorable subgroup with low risk of relapse

Annals of oncology, 2022-11, Vol.33, p.S1523-S1523

2022

Volltextzugriff (PDF)

EP12.01-31 Updated First-line Osimertinib in Asian patients with Advanced EGFR-mutated Lung Cancer

Journal of thoracic oncology, 2023-11, Vol.18 (11), p.S652-S653

2023

Volltextzugriff (PDF)

652O Randomized phase III VANCE study: Gemcitabine and carboplatin (GC) followed by Epstein Barr virus-specific autologous cytotoxic T lymphocytes (EBV-CTL) versus the same chemotherapy as first-line treatment for advanced nasopharyngeal carcinoma (NPC)

Annals of oncology, 2022-09, Vol.33, p.S840

2022

Volltextzugriff (PDF)

192P ddPCR versus plasma NGS in detecting clearance of plasma EGFR mutations

Journal of thoracic oncology, 2023-04, Vol.18 (4), p.S145

2023

Volltextzugriff (PDF)

266O Combination ipilimumab and nivolumab in recurrent/metastatic nasopharyngeal carcinoma (R/M NPC): Updated efficacy and safety analysis of NCT03097939

Annals of oncology, 2020-11, Vol.31, p.S1347-S1347

2020

Volltextzugriff (PDF)

1221P Outcomes of EGFR-mutant NSCLC patients with de novo brain metastases by upfront treatment

Annals of oncology, 2021-09, Vol.32, p.S970-S970

2021

Volltextzugriff (PDF)

P2.13-02 Dynamic Tracking of Bespoke Circulating Tumour DNA During Multi-Modality Therapy for Locally Advanced NSCLC (LA-NSCLC)

Journal of thoracic oncology, 2022-09, Vol.17 (9), p.S155-S156

2022

Volltextzugriff (PDF)

EP16.03-036 Clinical and Genomic Features of HER2 exon 20 Insertion Mutations in East Asian NSCLC

Journal of thoracic oncology, 2022-09, Vol.17 (9), p.S605

2022

Volltextzugriff (PDF)

A phase I pharmacokinetic study of metronomic vinorelbine and sorafenib using two schedules in Asian non-small cell lung cancer (NSCLC) patients

Annals of oncology, 2017-11, Vol.28, p.x39-x40

2017

Volltextzugriff (PDF)

Final Results of Local-Regional Control and Late Toxicity of RTOG 9003: A Randomized Trial of Altered Fractionation Radiation for Locally Advanced Head and Neck Cancer

International journal of radiation oncology, biology, physics, 2014-05, Vol.89 (1), p.13-20

2014

Volltextzugriff (PDF)

T790M co-exists with other secondary resistance mechanisms in EGFR mutation positive NSCLC and are associated with inferior outcomes

Annals of oncology, 2017-04, Vol.28, p.ii46-ii47

2017

Volltextzugriff (PDF)

230P Clinicopathologic and molecular features of STK11-mutated NSCLC

ESMO open, 2024-03, Vol.9, p.102880, Article 102880

2024

Volltextzugriff (PDF)

1 – 25 von 231

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(187)
Mit Volltextzugriff
(201)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(141)
Life Sciences & Biomedicine
(109)
Humans
(84)
Female
(58)
Male
(53)
Biological And Medical Sciences
(42)
Middle Aged
(40)
Medical Sciences
(36)
Oncology
(35)
Adult
(34)
Aged
(33)
Technology
(24)
Animals
(21)
Engineering
(17)
Physics
(17)
Radiology, Nuclear Medicine & Medical Imaging
(17)
Aged, 80 And Over
(16)
Tumors
(16)
Radiology
(15)
Hematology, Oncology And Palliative Medicine
(14)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Docetaxel is effective in heavily pretreated patients with disseminated nasopharyngeal carcinoma

Clinicopathological characteristics and outcome of advanced ROS1-positive non-small cell lung cancer in Asian patients

Real world data on epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI) use in advanced/metastatic non-small cell lung cancer (NSCLC) with EGFR mutations in Singapore

Somatostatin receptor 2 expression and clinical significance in pulmonary lymphoepithelioma-like carcinoma

Nuclear expression of MATK is a novel marker of type II enteropathy-associated T-cell lymphoma

A Phase 1 dose-finding and pharmacodynamic study of rapamycin in combination with bevacizumab in patients with unresectable hepatocellular carcinoma

Gefitinib, cisplatin, and concurrent radiotherapy for locally advanced head and neck cancer: EGFR FISH, protein expression, and mutational status are not predictive biomarkers

Pan-Asian adaptation of the EHNS–ESMO–ESTRO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with squamous cell carcinoma of the head and neck

Herbal medicines and perioperative care

Barriers to implementing a national health screening program for men in Malaysia: An online survey of healthcare providers

Different cellular p16INK4a localisation may signal different survival outcomes in head and neck cancer

Assessing subjective and psychomotor effects of the herbal medication valerian in healthy volunteers

911P Post-radiotherapy (RT) Epstein-Barr virus (EBV) DNA dynamics identifies optimal timepoint for stratification of high-risk nasopharyngeal carcinoma (NPC)

227MO Characterization of minimal residual disease (MRD) post-radiotherapy (RT) in nasopharyngeal carcinoma (NPC) patients identifies a favorable subgroup with low risk of relapse

EP12.01-31 Updated First-line Osimertinib in Asian patients with Advanced EGFR-mutated Lung Cancer

652O Randomized phase III VANCE study: Gemcitabine and carboplatin (GC) followed by Epstein Barr virus-specific autologous cytotoxic T lymphocytes (EBV-CTL) versus the same chemotherapy as first-line treatment for advanced nasopharyngeal carcinoma (NPC)

192P ddPCR versus plasma NGS in detecting clearance of plasma EGFR mutations

266O Combination ipilimumab and nivolumab in recurrent/metastatic nasopharyngeal carcinoma (R/M NPC): Updated efficacy and safety analysis of NCT03097939

1221P Outcomes of EGFR-mutant NSCLC patients with de novo brain metastases by upfront treatment

P2.13-02 Dynamic Tracking of Bespoke Circulating Tumour DNA During Multi-Modality Therapy for Locally Advanced NSCLC (LA-NSCLC)

EP16.03-036 Clinical and Genomic Features of HER2 exon 20 Insertion Mutations in East Asian NSCLC

A phase I pharmacokinetic study of metronomic vinorelbine and sorafenib using two schedules in Asian non-small cell lung cancer (NSCLC) patients

Final Results of Local-Regional Control and Late Toxicity of RTOG 9003: A Randomized Trial of Altered Fractionation Radiation for Locally Advanced Head and Neck Cancer

T790M co-exists with other secondary resistance mechanisms in EGFR mutation positive NSCLC and are associated with inferior outcomes

230P Clinicopathologic and molecular features of STK11-mutated NSCLC

Suchergebnisse filtern